Corvus Pharmaceuticals, Inc. (CRVS) Insider Trading
Sector: Biotechnology · Market Cap: $1.3B · 0 insider purchases in the last 7 days
No open market insider purchases at Corvus Pharmaceuticals, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track CRVS on your watchlist.
Start for FreeAbout Corvus Pharmaceuticals, Inc. Insider Trading
2 insiders at Corvus Pharmaceuticals, Inc. (CRVS) have purchased stock in the past 90 days, totaling $334K across 3 transactions (28,632 shares).
The most recent purchase was by Director Moore David Scott on June 11, 2026 — a $250K buy of 21,700 shares at $11.53, bringing his total holdings to 21,700 shares.
Insiders who purchased: Moore David Scott (Director, 1 buy totaling $250K); MILLER RICHARD A MD (CEO, 2 buys totaling $83K).
This insider buying is notable given that CRVS had no recorded open market purchases in the nine months before that.
CRVS is in the Biotechnology sector within the Biotechnology industry with a market cap of $1.3B.
Track CRVS insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.